ArticleBMC research notes2012

Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study.

Lamiaa Boulaamane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.